Walleye Capital’s Rockwell Medical RMTI Stock Holding History

Walleye Capital’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,956	Closed	-$435K	–	5440
2024 Q3	$435K	Buy	+10,956	New	+$295K	﹤0.01%	3427

Other funds holding RMTI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Walleye Capital's RMTI Position: Q4 2024 in Review

Walleye Capital sold out of Rockwell Medical (RMTI) in Q4 2024, closing a stake of 10,956 shares — an estimated $435K sold.

Walleye Capital first reported a position in RMTI in Q3 2024 and held it in 1 quarter. The position peaked at $435K in Q3 2024. 53 funds tracked by Wall St. Rank hold RMTI as of Q4 2024.

Walleye Capital reported no remaining Rockwell Medical position as of Q4 2024 after selling out during the quarter.
Walleye Capital sold 10,956 Rockwell Medical shares in Q4 2024, an estimated $435K.
Walleye Capital first reported a position in Rockwell Medical in Q3 2024 and held it in 1 quarter.
Walleye Capital's Rockwell Medical position peaked at $435K in Q3 2024.
53 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.